Robert L. Smith

15.3k citations

301 papers · 11.2k · 1 hit paper · h-index 55

Impact in

Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
Clinical Biochemistry top 0.5%
- Metabolism and Genetic Disorders

Papers in

Molecular Biology 76
Oncology 47
- Drug Transport and Resistance Mechanisms 30

Co-authors: R. T. Williams (27 shared papers)Chi‐Sun Wang (1 shared paper)P. Millburn (23 shared papers)John Caldwell (38 shared papers)Rashmi R. Shah (4 shared papers)S. C. Mitchell (17 shared papers)R. T. Williams (12 shared papers)Colin T. Dolphin (11 shared papers)
Journals: Xenobiotica (34 papers)Food and Chemical Toxicology (29 papers)Journal of Medicinal Chemistry (15 papers)Biochemical Pharmacology (14 papers)Biochemical Society Transactions (13 papers)
Partner nations: United Kingdom United States Norway

In The Last Decade

Robert L. Smith

297 papers receiving 10.5k citations

Robert L. Smith's Hit Papers

align trajectories log scale

Lowry determination of protein in the presence of Triton X-100 1975 · 734 citations

Peers

Replace Peter J. O’Brien with:

Peter J. O’Brien Canada

Henrik E. Poulsen Denmark

Giuseppe Poli Italy

Gérard Siest France

Umberto Dianzani Italy

Giorgio Bellomo Italy

Herman Adlercreutz Finland

Kenneth D.R. Setchell United States

Robert J. Williams United Kingdom

Stephen Barnes United States

Robert L. Smith relative to Peter J. O’Brien Canada Peter J. O’Brien's profile →

Citations per field

00.5×1.5×

Peter J. O’Brien · 1×

×0.9 2k/2k

PHARM

×1.2 700/583

CB

×0.4 573/1k

BIOCH

×0.7 867/1k

CR

×1.4 2k/1k

ONCOL

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by Robert L. Smith

Since Specialization

Citations

This map shows the geographic impact of Robert L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Smith more than expected).

Fields of papers citing papers by Robert L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Smith. The network helps show where Robert L. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert L. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert L. Smith Line = papers co-authored together Robert L. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 301 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lowry determination of protein in the presence of Triton X-100 Analytical Biochemistry ·Chi‐Sun Wang, Robert L. Smith Hit paper breakdown →	1975	734
2	Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase Inhibitor Science ·Nancy E. Kohl, Scott D. Mosser, S. J. DESOLMS, Elizabeth A. Giuliani, David L. Pompliano, Samuel Graham, Robert L. Smith, Edward M. Scolnick, Allen Oliff, W. Wayt Gibbs	1993	485
3	Identification of FOXP2 Truncation as a Novel Cause of Developmental Speech and Language Deficits The American Journal of Human Genetics ·Kay MacDermot, Elena Bonora, Nuala Sykes, Anne-Marie Coupe, Cecilia Lai, Sonja C. Vernes, Faraneh Vargha‐Khadem, Fiona McKenzie, Robert L. Smith, Anthony P. Monaco, Simon E. Fisher	2005	292
4	Preoperative Evaluation of Cardiac Failure and Ischemia in Elderly Patients by Cardiopulmonary Exercise Testing CHEST Journal ·Raul Older, Robert L. Smith, Beter Courtney, Rodney Hone	1993	237
5	Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors Journal of Medicinal Chemistry ·George D. Hartman, Melissa S. Egbertson, Wasyl Halczenko, William L. Laswell, Mark E. Duggan, Robert L. Smith, Adel M. Naylor, Patricia D. Manno, Robert J. Lynch	1992	233
6	Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome Nature Genetics ·Colin T. Dolphin, Azara Janmohamed, Robert L. Smith, Elizabeth A. Shephard, lan R. Phillips	1997	215
7	The metabolic fate of amphetamine in man and other species Biochemical Journal ·L. G. Dring, Robert L. Smith, R. T. Williams	1970	208
8	Safety assessment of allylalkoxybenzene derivatives used as flavouring substances — methyl eugenol and estragole Food and Chemical Toxicology ·Robert L. Smith, Timothy B. Adams, John Doull, V.J. Feron, Jay I. Goodman, Lawrence J. Marnett, Philip S. Portoghese, William J. Waddell, Bernard M. Wagner, Adrianne E. Rogers, John Caldwell, I.G. Sipes	2002	202
9	Addressing phenoconversion: the Achilles' heel of personalized medicine British Journal of Clinical Pharmacology ·Rashmi R. Shah, Robert L. Smith	2014	186
10	Recent progress in the consideration of flavoring ingredients under the Food Additives Amendment. 15. GRAS substances. Food technology ·George A. Burdock, Bernard M. Wagner, Robert L. Smith, I.C. Munro, Paul M. Newberne	1990	169
11	The fate of benzoic acid in various species Biochemical Journal ·James Winfred Bridges, M.R. French, Robert L. Smith, R. T. Williams	1970	168
12	The exogenous origin of trimethylamine in the mouse Metabolism ·Makram M. Al-Waiz, Momir Mikov, S. C. Mitchell, Robert L. Smith	1992	162
13	The FEMA GRAS assessment of benzyl derivatives used as flavor ingredients Food and Chemical Toxicology ·Timothy B. Adams, Samuel M. Cohen, John Doull, V.J. Feron, Jay I. Goodman, Lawrence J. Marnett, I.C. Munro, Philip S. Portoghese, Robert L. Smith, William J. Waddell, Bernard M. Wagner	2005	154
14	Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized Medicine Drug Metabolism and Disposition ·Rashmi R. Shah, Robert L. Smith	2014	153
15	Biliary excretion of foreign compounds. Biphenyl, stilboestrol and phenolphthalein in the rat: molecular weight, polarity and metabolism as factors in biliary excretion Biochemical Journal ·P. Millburn, Robert L. Smith, R. T. Williams	1967	151
16	The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species PubMed ·Margaret O. James, Robert L. Smith, R. T. Williams, Marcus Reidenberg	1972	131
17	Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats Atherosclerosis ·James P. Corsetti, Janet D. Sparks, Richard G. Peterson, Robert L. Smith, C E Sparks	2000	131
18	Species variations in the threshold molecular-weight factor for the biliary excretion of organic anions Biochemical Journal ·P. C. Hirom, P. Millburn, Robert L. Smith, R. T. Williams	1972	130
19	Toxicity and Teratogenicity of Optical Isomers of Thalidomide Nature ·Sergio Fabro, Robert L. Smith, R. T. Williams	1967	125
20	Differential Developmental and Tissue‐Specific Regulation of Expression of the Genes Encoding Three Members of the Flavin‐Containing Monooxygenase Family of Man, FMO1, FMO3 and FMO4 European Journal of Biochemistry ·Colin T. Dolphin, Timothy E. Cullingford, Elizabeth A. Shcphard, Robert L. Smith, Ian Phillips	1996	124

About Robert L. Smith

Robert L. Smith is a scholar working on Molecular Biology, Oncology, Pharmacology, Clinical Biochemistry and Biochemistry, having authored 301 papers that have together received 11.2k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (33 papers), Pharmacogenetics and Drug Metabolism (31 papers), Drug Transport and Resistance Mechanisms (30 papers), Carcinogens and Genotoxicity Assessment (19 papers), Schizophrenia research and treatment (17 papers), Amino Acid Enzymes and Metabolism (13 papers), Analytical Chemistry and Chromatography (13 papers) and Effects and risks of endocrine disrupting chemicals (13 papers). The work is most often cited by research in Pharmacology (1.9k citations), Clinical Biochemistry (700 citations), Biochemistry (573 citations), Cancer Research (867 citations) and Oncology (1.5k citations). Robert L. Smith has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include R. T. Williams, Chi‐Sun Wang, P. Millburn, John Caldwell, Rashmi R. Shah, S. C. Mitchell, R. T. Williams, Colin T. Dolphin, Bernard M. Wagner and R. Ayesh. Their work appears in journals such as Xenobiotica, Food and Chemical Toxicology, Journal of Medicinal Chemistry, Biochemical Pharmacology and Biochemical Society Transactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Robert L. Smith

Impact in

Papers in i

In The Last Decade

Robert L. Smith

Robert L. Smith's Hit Papers

Peers

Countries citing papers authored by Robert L. Smith

Fields of papers citing papers by Robert L. Smith

All Works

About Robert L. Smith

Explore authors with similar magnitude of impact

Papers in